Concord Biotech
NSEI:CONCORDBIO Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 7 Fair Values set on narratives written by author
WA
Consensus Narrative from 5 Analysts
Launching New Niche APIs And Commercializing Injectable Plant Will Ensure Future Success
Key Takeaways Expansion in formulation business and niche APIs could bolster market share, particularly in oncology and anti-infectives, enhancing revenue and earnings. Strategic market targeting, partnerships, and renewable energy investments are poised to drive revenue growth, operational cost reduction, and improved net margins.
View narrative₹1.91k
FV
13.5% undervalued intrinsic discount22.34%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
2 days ago author updated this narrative